SE7601125L - PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT - Google Patents
PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENTInfo
- Publication number
- SE7601125L SE7601125L SE7601125A SE7601125A SE7601125L SE 7601125 L SE7601125 L SE 7601125L SE 7601125 A SE7601125 A SE 7601125A SE 7601125 A SE7601125 A SE 7601125A SE 7601125 L SE7601125 L SE 7601125L
- Authority
- SE
- Sweden
- Prior art keywords
- procedure
- preparation
- cytotoxic agent
- cytotoxic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicinal Preparation (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4695/75A GB1496011A (en) | 1974-11-22 | 1975-02-04 | Defoaming composition |
Publications (1)
Publication Number | Publication Date |
---|---|
SE7601125L true SE7601125L (en) | 1976-08-05 |
Family
ID=9782062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7601125A SE7601125L (en) | 1975-02-04 | 1976-02-03 | PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS51126281A (en) |
BE (1) | BE838273A (en) |
DK (1) | DK43676A (en) |
NL (1) | NL7601132A (en) |
SE (1) | SE7601125L (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57143326A (en) * | 1981-03-03 | 1982-09-04 | Teijin Ltd | Polymer linked to cellular toxic substance and its preparation |
DE3205847A1 (en) * | 1981-05-08 | 1982-12-16 | Farmitalia Carlo Erba S.p.A., 20159 Milano | Daunorubicin-protein conjugates |
JPS60172935A (en) * | 1984-02-16 | 1985-09-06 | Green Cross Corp:The | Preparation of composite material of substance having carcinostatic action |
JPS611622A (en) * | 1984-06-14 | 1986-01-07 | Teijin Ltd | Cytotoxic complex and preparation thereof |
FR2586564B1 (en) * | 1985-09-04 | 1989-04-07 | Pierre Tran Ba Loc | IMMUNOSUPPRESSIVE COMPOUNDS AND PROCESS FOR THEIR PREPARATION |
JPS62228025A (en) * | 1985-12-27 | 1987-10-06 | Teijin Ltd | Production of antibody complex |
JPH0662438B1 (en) * | 1986-08-28 | 1994-08-17 | Teijin Ltd | |
DE3788058T2 (en) * | 1986-08-28 | 1994-04-21 | Teijin Ltd | CELL TOXIC ANTIBODY COMPLEX AND METHOD FOR THE PRODUCTION THEREOF. |
US5149782A (en) * | 1988-08-19 | 1992-09-22 | Tanox Biosystems, Inc. | Molecular conjugates containing cell membrane-blending agents |
JP2626654B2 (en) * | 1990-03-31 | 1997-07-02 | 科学技術振興事業団 | Targeting high molecular weight pharmaceutical compounds and intermediates thereof |
-
1976
- 1976-02-03 SE SE7601125A patent/SE7601125L/en not_active Application Discontinuation
- 1976-02-03 JP JP51010786A patent/JPS51126281A/en active Pending
- 1976-02-03 DK DK43676*#A patent/DK43676A/en not_active Application Discontinuation
- 1976-02-04 NL NL7601132A patent/NL7601132A/en not_active Application Discontinuation
- 1976-02-04 BE BE164096A patent/BE838273A/en unknown
Also Published As
Publication number | Publication date |
---|---|
BE838273A (en) | 1976-08-04 |
NL7601132A (en) | 1976-08-06 |
DK43676A (en) | 1976-08-05 |
JPS51126281A (en) | 1976-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE437767B (en) | PROCEDURE FOR THE PREPARATION OF AN ANTI-TUMORARY MEDICINAL PRODUCT | |
SE433208B (en) | PROCEDURE FOR THE PREPARATION OF PHENOLETERS | |
SE431088B (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY EFFECTIVE BENZYDRYLSULPHINYL DERIVATIVES | |
NO147450C (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CHINAZOLONE DERIVATIVES | |
SE431883B (en) | PROCEDURE FOR THE PREPARATION OF A PAINTING AGENT | |
SE7605139L (en) | PROCEDURE FOR THE PREPARATION OF WATER-INTAKING CELLULOSAETERS | |
SE430336B (en) | IMPROVED PROCEDURE FOR THE PREPARATION OF AMOXICILLIN-FREEHYDRATE | |
AR217629A1 (en) | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF TIENOTETRAHIDROPIRIDINA | |
SE7601125L (en) | PROCEDURE FOR THE PREPARATION OF A CYTOTOXIC AGENT | |
SE7504882L (en) | PROCEDURE FOR THE PREPARATION OF A NEW PHARMACEUTICAL PREPARATION. | |
SE443142B (en) | PROCEDURE FOR THE PREPARATION OF RIFAMYCIN COMPOUNDS | |
SE7606116L (en) | PROCEDURE FOR THE PREPARATION OF 3-PHENOXIDE BENZALDEHIDS | |
SE7600910L (en) | PROCEDURE FOR THE PREPARATION OF POLYURETHANES | |
SE7604781L (en) | PROCEDURE FOR THE PREPARATION OF DIARYLHYDROXIBUTYLAMINES | |
SE409455B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF NITROIMIDAZOLYL-CHINAZOLINE DERIVATIVES | |
SE421692B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF SPIRO (CYCLOPROPANE-1,2Ÿ-INDOLINE) -3Ÿ-ON COMPOUNDS | |
SE414029B (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE FENTIAZINE DERIVATIVES | |
SE7601836L (en) | PROCEDURE FOR THE PREPARATION OF A DIMERKAPTOEL TYLETER DERIVATIVE | |
SE404186B (en) | PROCEDURE FOR THE PREPARATION OF CYCLOPROPANEL DERIVATIVES | |
SE7511011L (en) | PROCEDURE FOR THE PREPARATION OF A SULFUR-CONTAINING PYRIDINE DERIVATIVE | |
SE423814B (en) | PROCEDURE FOR THE PREPARATION OF DIBENSOFENAZINE OR ACENAPHTOKINOXALIN DERIVATIVES | |
SE421793B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF NAFTYRIDINE-SUBSTITUTED PYRROLLER DERIVATIVES | |
SE7610637L (en) | PROCEDURE FOR THE PREPARATION OF 2-ALKYLINDANES | |
SE446726B (en) | PROCEDURE FOR THE PREPARATION OF 16-METOXIPROSTAGLANDINES | |
SE7605427L (en) | PROCEDURE FOR THE PREPARATION OF CHLORCYANE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 7601125-3 |